Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Balbir

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Neuroscience|September 24, 2004
Identification of M1 and M2 muscarinic acetylcholine receptors in the cat carotid body chemosensory systemM Shirahata, S Hirasawa, M Okumura, et al.
Rheumatology (Oxford, England)|October 26, 2006
Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 yearsV Strand, A Balbir-Gurman, K Pavelka, et al.
Annals of the Rheumatic Diseases|February 7, 2002
Non-invasive measurement of biomechanical skin properties in systemic sclerosisA Balbir-Gurman, C P Denton, B Nichols, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 22, 2001
A model of sleep-disordered breathing in the C57BL/6J mouseY Tagaito, V Y Polotsky, M J Campen, et al.
Annals of the Rheumatic Diseases|November 6, 2007
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral responseS Oren, M Mandelboim, Y Braun-Moscovici, et al.
Scandinavian Journal of Rheumatology|July 25, 2018
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) databaseP E Carreira, L Carmona, B E Joven, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresJ Fransen, D Popa-Diaconu, R Hesselstrand, et al.
Annals of the Rheumatic Diseases|March 13, 2009
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosisY Allanore, C Meune, M C Vonk, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Neuroscience|September 24, 2004
Identification of M1 and M2 muscarinic acetylcholine receptors in the cat carotid body chemosensory systemM Shirahata, S Hirasawa, M Okumura, et al.
Rheumatology (Oxford, England)|October 26, 2006
Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 yearsV Strand, A Balbir-Gurman, K Pavelka, et al.
Annals of the Rheumatic Diseases|February 7, 2002
Non-invasive measurement of biomechanical skin properties in systemic sclerosisA Balbir-Gurman, C P Denton, B Nichols, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 22, 2001
A model of sleep-disordered breathing in the C57BL/6J mouseY Tagaito, V Y Polotsky, M J Campen, et al.
Annals of the Rheumatic Diseases|November 6, 2007
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral responseS Oren, M Mandelboim, Y Braun-Moscovici, et al.
Scandinavian Journal of Rheumatology|July 25, 2018
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) databaseP E Carreira, L Carmona, B E Joven, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresJ Fransen, D Popa-Diaconu, R Hesselstrand, et al.
Annals of the Rheumatic Diseases|March 13, 2009
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosisY Allanore, C Meune, M C Vonk, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Pageof 3